(Q43668255)

25 November 2017

title

Cerebrovascular melatonin MT1-receptor alterations in patients with Alzheimer's disease (English)

1 reference

25 November 2017

0 references

Savaskan E

1

1 reference

25 November 2017

Olivieri G

2

1 reference

25 November 2017

Brydon L

3

1 reference

25 November 2017

Jockers R

4

1 reference

25 November 2017

Kräuchi K

5

1 reference

25 November 2017

Wirz-Justice A

6

1 reference

25 November 2017

Müller-Spahn F

7

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

308

1 reference

25 November 2017

issue

1

1 reference

25 November 2017

page(s)

9-12

1 reference

Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901967-X

7 January 2021

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901967-X

7 January 2021

Nocturnal melatonin excretion is decreased in patients with migraine without aura attacks associated with menses

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901967-X

7 January 2021

Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901967-X

7 January 2021

Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901967-X

7 January 2021

Melatonin mediates two distinct responses in vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901967-X

7 January 2021

Impaired nocturnal melatonin excretion and changes of immunological status in ischaemic stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901967-X

7 January 2021

Melatonin directly constricts rat cerebral arteries through modulation of potassium channels

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901967-X

7 January 2021

Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901967-X

7 January 2021

Immunohistochemical localization of EphA5 in the adult human central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901967-X

7 January 2021

An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901967-X

7 January 2021

Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901967-X

7 January 2021

Expression of melatonin receptors in arteries involved in thermoregulation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901967-X

7 January 2021

Melatonin potentiates contractile responses to serotonin in isolated porcine coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901967-X

7 January 2021

10.1016/S0304-3940(01)01967-X

Identifiers

DOI

1 reference

25 November 2017

1 reference